PALATIN TECHNOLOGIES, INC. Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs
PALATIN TECHNOLOGIES, INC. (PTN) had Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs of $182.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts · last filed 2017-05-15
- 2017-03-31: Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs $182.00K.
- 2016-12-31: Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs $29.62K.
- 2016-09-30: Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs $25.76K.
- 2016-06-30: Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs $23.01K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs |
|---|---|
| 2017-03-31 | $182.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $29.62K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $25.76K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $23.01K 10-Q · filed 2017-05-15 |
| 2016-03-31 | $117.36K 10-Q · filed 2016-05-16 |
| 2015-06-30 | $72.82K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |